CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.
Similar Posts
Laboratorios Farmeceuticos Rovi, SA – 5/19/2023
Laboratorios Farmeceuticos Rovi, SA – 5/19/2023. Country: Spain. Record Type: 483KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged
Newtown, Pennsylvania, KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13” on one side and plain on the other side” to the consumer level. The batch was distribJanssen Vaccines Corp., A Johnson & Johnson Company – 713194 – 07/18/2025
CGMP/Finished Pharmaceuticals/AdulteratedAspiration System Correction: Calyxo Updates Use Instructions for CVAC Aspiration Systems
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramEugia Pharma Specialities Limited – 2/6/2026
Eugia Pharma Specialities Limited – 2/6/2026. Country: India. Record Type: 483Rhino 69 Gummy may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Rhino 69 Gummy, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.